Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Restatement
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Grant or award CEO acquired 105,000 shares (grant or award)
  8. 4 Grant or award Chief Business Officer acquired 40,000 shares (grant or award)
  9. 4 Grant or award General Counsel acquired 25,000 shares (grant or award)
  10. 4 Grant or award SVP, Finance and Accounting acquired 25,000 shares (grant or award)
  11. 8-K Event Material agreement
  12. 8-K Event Material agreement
  13. 8-K Event Results of operations
  14. 10-Q Report Quarterly Report
  15. CT ORDER Other Confidential Order
  16. 8-K Event Executive or director change
  17. 8-K Event Executive or director change
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 41 · 801 filings